DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

Xiao Shen

CEO

Canton Biologics Co., Ltd.

Guangzhou, China

14 profile visitsSpeakerCompanies/Industry

My organisation

Welcome to the Canton Biologics booth — we're at B9! Canton Biologics is a globally integrated CDMO, operating four core sites across China and Germany and serving over 100 biopharma clients worldwide. Our capabilities span six advanced solution areas: Innovative Drug Solutions, Biosimilar Solutions, ATMP Solutions (including oncolytic viruses, CAR-T cell therapies, LBPs, and exosome-based therapies), Biologics Solutions for Companion Animals, Biologics Solutions for Livestock and Poultry, and Recombinant Products for Healthcare & Lifestyle. Supported by robust quality systems aligned with EMA, FDA, and NMPA standards, we enable the development of even the most challenging-to-express proteins. We drive bioprocess innovation through high-titer expression platforms (up to 39 g/L), next-generation cell lines, proprietary vector systems, and accelerated DNA-to-BLA timelines.
Read more

About me

Bioprocessing professional and biotech entrepreneur with experience spanning academic research and industrial biologics development.

Holds a PhD from EPFL (École Polytechnique Fédérale de Lausanne), Switzerland, with research focused on cell culture and bioprocessing technologies. Subsequently gained industry experience at ExcellGene SA, working on CHO cell line development and upstream bioprocess platforms.

Founder and CEO of Canton Biologics, a biologics CDMO established in 2016 to support global biopharmaceutical partners with scalable and efficient development and manufacturing solutions.

Professional interests include biologics manufacturing technologies, scalable cell culture systems, and international collaboration in the biopharmaceutical industry.

Social media

Additional questions

Interests

VaccinesPharmaceutical / TherapeuticsOther biologicalsLivestockEnabling technology (assay, delivery, formulation, manufacturing, ...)Companion animals

What is your primary goal for attending this event?

Networking with industry professionalsExploring potential collaborationsLearning about the latest trends in healthtechShowcasing products or solutions

Speaker sessions (1)

Wednesday, 20 May 2026

14:00 - 14:45

Masterclass 4: A High-Titer CHO Cell-Based Integrated Platform to Accelerate Veterinary Biologics Development

Location:BMCC - 3rd Floor - Swan RoomTrack:Masterclass

This session presents an integrated CHO-based platform for veterinary biologics, enabling efficient development and scalable manufacturing of recombinant proteins and vaccines while reducing costs and supporting broader adoption in animal health.

Sign-ups available from 1 Apr 2026, 00:00 to 20 May 2026, 14:45